Literature DB >> 87832

Karyotypic conversion in Ph1-positive chronic myeloid leukaemia with combination chemotherapy.

J C Sharp, M V Joyner, A W Wayne, J Kemp, M Crofts, A D Birch, G McArthur, S Lai, H Sterndale, Y Williams.   

Abstract

Twelve previously untreated patients with Ph1-positive chronic myeloid leukaemia received combination chemotherapy soon after diagnosis. There was karyotypic conversion in five: in four, the percentage of Ph1-positive cells fell to 10 or less. In two other patients, who had mosaic karyotypes at presentation, the percentage fell to 5% and zero.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87832     DOI: 10.1016/s0140-6736(79)92008-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  6 in total

1.  Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha.

Authors:  R Hehlmann; B Anger; D Messerer; R Zankovich; L Bergmann; H J Kolb; P Meyer; U Essers; U Queisser; H Vaupel
Journal:  Blut       Date:  1988-02

2.  Aggressive or non-aggressive tumor therapy.

Authors:  P Reizenstein
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  Haemopoietic stem cell autografts for leukaemia.

Authors:  J M Goldman
Journal:  Blut       Date:  1980-08

Review 4.  Recent advances in haematology.

Authors:  D Samson; I Chanarin; C D Reid
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

Review 5.  Benign hematopoietic progenitors in chronic myeloid leukemia: current status and future prospects.

Authors:  F Cervantes; C Rozman
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

6.  Buffy coat autografts for patients with chronic granulocytic leukaemia in transformation.

Authors:  J M Goldman; D Catovsky; A W Goolden; S A Johnson; D A Galton
Journal:  Blut       Date:  1981-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.